Pharmigene (ROCO:7595) FCF Margin % : -89.03% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Pharmigene FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pharmigene's Free Cash Flow for the six months ended in Dec. 2023 was NT$-70.4 Mil. Pharmigene's Revenue for the six months ended in Dec. 2023 was NT$79.1 Mil. Therefore, Pharmigene's FCF Margin % for the quarter that ended in Dec. 2023 was -89.03%.

As of today, Pharmigene's current FCF Yield % is -87.14%.

The historical rank and industry rank for Pharmigene's FCF Margin % or its related term are showing as below:

ROCO:7595' s FCF Margin % Range Over the Past 10 Years
Min: -561.65 Med: -29.36 Max: -21.52
Current: -561.65

During the past 7 years, the highest FCF Margin % of Pharmigene was -21.52%. The lowest was -561.65%. And the median was -29.36%.

ROCO:7595's FCF Margin % is ranked worse than
89.55% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.405 vs ROCO:7595: -561.65

Pharmigene FCF Margin % Historical Data

The historical data trend for Pharmigene's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmigene FCF Margin % Chart

Pharmigene Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-37.82

-21.52

-29.36

-25.45

-561.65

Pharmigene Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial							-21.05	-50.26	-8.10	-1,259.62	-89.03

Competitive Comparison of Pharmigene's FCF Margin %

For the Diagnostics & Research subindustry, Pharmigene's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmigene's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pharmigene's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmigene's FCF Margin % falls into.

Pharmigene FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pharmigene's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-745.348	/	132.707
	=	-561.65 %

Pharmigene's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-70.443	/	79.127
	=	-89.03 %

Pharmigene FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pharmigene's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmigene (ROCO:7595) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pharmigene Inc (ROCO:7595) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 101 Ruihu Street, 5th Floor, Neihu District, Taipei, TWN, 11494

Website

https://www.pharmigene.com

Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.

Pharmigene (ROCO:7595) Headlines

No Headlines